PHENYTOIN SODIUM

Post-LOE

phenytoin sodium

Teva

ANDAINJECTIONINJECTABLE

Approved

Sep 2006

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

PHENYTOIN SODIUM (phenytoin sodium) by Teva is 12. Approved for generalized tonic-clonic status epilepticus, prevention, treatment of seizures occurring during neurosurgery. First approved in 2006.

Drug data last refreshed 18h ago

Mechanism of Action

12.1 Mechanism of Action The precise mechanism by which phenytoin exerts its therapeutic effect has not been established but is thought to involve the voltage-dependent blockade of membrane sodium channels resulting in a reduction in sustained high-frequency neuronal discharges. 12.3…

Worked on PHENYTOIN SODIUM at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

PHENYTOIN SODIUM

Mechanism of Action

Indications (3)